MICHAEL LAGOE: Open Payments
NPI 1730698044 · ORANGE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,134 in 178 payments from 27 companies in 2025. Trend: 2023 $3,528 · 2024 $4,501 · 2025 $4,134
Food & beverage: $3,154Consulting: $980
| Company | Payments | Amount |
|---|---|---|
| Amneal Pharmaceuticals LLC | 9 | $1,120 |
| ABBVIE INC. | 34 | $579 |
| Neurocrine BioSciences, Inc. | 17 | $371 |
| PFIZER INC. | 25 | $269 |
| ACADIA Pharmaceuticals Inc | 16 | $269 |
| Teva Pharmaceuticals USA, Inc. | 9 | $211 |
| MDD US Operations, LLC | 12 | $177 |
| Biogen, Inc. | 8 | $148 |
| Lilly USA, LLC | 6 | $124 |
| UCB, Inc. | 4 | $105 |
Products named: CREXONT, INGREZZA, NUPLAZID, AUSTEDO XR, NURTEC ODT, BOTOX, Leqembi, QULIPTA.
Industry payments across FL — which companies pay providers there.
